Skip to main content

Table 3 Doses of different APs in different disorders at discharge (N = 603a)

From: Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey

 

Chlorpromazine equivalent

Olanzapine

Quetiapine

Risperidone

Aripiprazole

Clozapine

Total Sample

231.56 ± 191.49

9.04 ± 5.80

185.13 ± 174.72

2.98 ± 1.71

9.13 ± 6.32

86.05 ± 117.15

MDD

199.06 ± 192.67

7.66 ±  5.62

180.08 ±  175.44

3.14 ± 1.57

10.33 ±  7.16

95.94 ± 164.72

AD

144.32 ± 144.67

6.97 ±  5.75

111.31 ±  121.38

–

5.83 ± 3.82

85 ±  99.62

DCR

336.22 ± 200.7

11.18 ± 5.79

266.43 ±  210.70

3.32 ± 1.49

16 ± 9.62

75 ±  35.36

OMD

285.78 ± 167.56

10.63 ± 5.49

232.35 ±  194.41

2.73 ±  1.42

6..5 ± 3.35

225

MDPS

214.82 ± 140.55

9.75 ± 5.19

208.09 ±  143.54

2.7 ± 1.06

7.5 ±  3.54

25

Dementia

138.02 ± 131.22

6.98 ±  5.53

103.33 ± 95

1.47 ± 1.76

10

12.5

SMD

206.56 ± 132.97

6.56 ± 3.99

200 ±  180.28

1

–

–

OCD

168.21 ± 75.64

5

250 ±  70.71

3

8.25 ± 4.42

–

Insomnia

150 ±  129.9

10

100

–

–

–

BEDO

284.50 ± 185.73

12.5 ±  3.54

333.33 ± 251.66

3.5 ± 0.7

7.5 ±  2.74

25

Other

308.65 ± 247

9.89 ± 6.52

247.22 ±  251.39

4.55 ± 1.95

6.88 ± 6.23

87.5 ±  53.03

  1. The data in the table was described with Mean ± Standard deviation
  2. aThere are 17 patients whose data of APs dose were not available
  3. APs antipsychotics, MDD major depression disorders, AD anxiety disorder, DCR dissociative (conversion) disorders, OMD organic mental disorders, MDPS mental disorders due to psychoactive substances, SMD somatoform disorders, OCD obsessive-compulsive disorder, BEDO behavioural and emotional disorders with onset usually occurring in childhood and adolescence